Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031203

Enrollment

Unknown

Registered

2020-03-24

Start date

2020-03-16

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

1:Blank

2:Moxibustion treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the above-mentioned diagnostic criteria and have reached the standards of separation and discharge after clinical treatment; 2. The patient was conscious, without aphasia, mental retardation, literacy, volunteered to participate in the trial, agreed to sign the informed consent and cooperated with the treatment.

Exclusion criteria

Exclusion criteria: 1. Cases of clinical treatment of pneumonia; 2. Those who cannot understand the content of the scale and cannot evaluate the curative effect; 3. Suicide-prone by the doctor; 4. pregnant women, those with severe cardiovascular and cerebrovascular, liver, kidney, hematopoietic system and other diseases; 5. Those who do not cooperate with the treatment plan; 6. The researcher thinks that others are not suitable for enrollment.

Design outcomes

Primary

Measure	Time frame
TCM Syndrome Scale;	—

Secondary

Measure	Time frame
Self-Rating Anxiety Scale ;	—

Countries

China

Contacts

Public ContactFu Liran

Zhengzhou People's Hospital

fuliran@126.com+86 15837117112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026